Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Nobuhle Titus, an MSF nurse technical support, packs sputum samples collected from a Luyanda site in the town of Vuma. Luyanda sites She collects and transports the samples from MSF’s Luyanda sites to the hospital where they are tested. Luyanda sites provide a link between patients and hospitals where patients can have sputum samples tested and receive information on TB and other diseases. This process makes the process of testing TB easier for patients who often stay far away from the hospital. Photograph by Tadeu Andre
Press release
Press release |
14 October 2020
Tuberculosis

MSF response to the release of WHO Global TB Report 2020

2 min
covid19_yemen_patientbeingmoved_jacobburns_2020_msf324285_3800px_0.jpg Photograph by Jacob Burns
Press release
Press release |
07 October 2020
COVID-19

In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic

4 min
An MSF Health Promoter speaks with people about how to keep safe during the COVID-19 pandemic. Photograph by Tadeu Andre
Press release
Press release |
03 August 2020
COVID-19

MSF applauds South Africa for championing health safeguards at meeting of WTO members

4 min
covid_conakry_genexpert_albertmasias_2020_msb19703_3800px Photograph by Albert Masias
Press release
Press release |
28 July 2020
COVID-19

COVID-19 test maker Cepheid overcharges and undersupplies WHO effort for developing countries

5 min
At MSF’s post-operative care hospital in Mosul (Iraq), infection and prevention control (IPC) measures are implemented. One of the pillars of IPC consists in cleaning, sterilizing and sanitizing. Here, an MSF nurse is preparing equipment prior to a surgery. Photograph by Mario Fawaz
Press release
Press release |
09 July 2020
Antimicrobial resistance

MSF response to global launch of: ‘A New Pharma Initiative takes on the Antibiotic Innovative Challenge’

MSF protested in front of the New York Stock Exchange in New York on January 22, 2020, demanding the pharmaceutical corporation Johnson & Johnson (J&J) make the tuberculosis (TB) drug bedaquiline available for all people with drug-resistant TB (DR-TB) for no more than a dollar a day. The price of this crucial drug must be lowered to reflect the joint contributions made in the research and development of this drug by taxpayers, and the global scientific and TB community, including by MSF itself. Photograph by Negin Allamehzadeh
Press release
Press release |
06 July 2020
Tuberculosis

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment

6 min
John * and Jean * hold each other’s arms in the CHK. Jean was diagnosed with HIV in 2010. He was hospitalized in June 2019 for the first time. A few weeks after his release, he had to return urgently for a new hospitalization. Photograph by Pablo Garrigos
Press release
Press release |
06 July 2020
HIV/AIDS

MSF response to the release of UNAIDS 2020 Global AIDS Update Report

3 min
The MSF treatment centre for COVID-19 patients at the Amirou Boubacar Diallo National Hospital in Niamey, Niger, has 50 beds, with the potential to accommodate up to 100 beds in case of a peak in patient numbers. Photograph by Nathalie San Gil
Press release
Press release |
01 July 2020
COVID-19
Africa

African Union says urgent need to address patents and technology barriers for access to future COVID-19 vaccines

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury